Medical Journal The Lancet confirms that the Russian COVID19 vaccine shows real promise as tests prove it works in creating antibodies and has no side-effects.
Results from two early-phase non-randomised vaccine trials in a total of 76 people indicate that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days.